Jonathan currently serves as the Chief Financial Officer of Moleac, a biopharmaceutical company based in Singapore. Prior to joining Moleac, Jonathan was an Associate Director in Corporate Finance and Business Development with Aslan Pharmaceuticals. Prior to Aslan, he was in the investment banking and equity research industry, last serving as the lead analyst covering healthcare and consumer with CIMB. Jonathan holds an MPhil in Management degree from the University of Cambridge and currently serves on the Board of Down Syndrome Association Singapore.